|
|
|
 |
Glyrite |
"Glyrite, with
its multi-factorial effects, deserves attention as a potentially
new standard in diabetes care."
read letter
M. Arthur Charles
M.D., Ph.D.
Professor of
Medicine/Diabetes
Glyrite, our smart molecule technology, is
a naturally occurring compound found in foods including parsley,
artichoke leaves, celery, peppers, olive oil, rosemary, lemons,
peppermint, sage, thyme, and many others, with antioxidant,
anti-inflammatory, anti-allergic, and immune-modulating
properties to suppress hyperactive immune systems and promote
healthy blood glucose levels.
Glyrite is
a Super-Nutrient from a class of naturally occurring molecules
known as bioflavonoids. It neutralizes free radicals such as
superoxide, the hydroxyl radical, and other reactive oxygen
compounds to help reduce oxidative stress and may help reduce
inflammation, regulate hyperactive immune systems, and promote
healthy carbohydrate metabolism. This
smart molecule, a citrus bioflavonoid, exerts a variety of
pharmacological activities and anti-oxidant properties
associated with its capacity to scavenge oxygen and nitrogen
species. It also shows potent anti-inflammatory activities by
inhibiting nuclear factor kappa B (NFkB) signaling in immune
cells.
 |
Doctor Endorsed.
|
|
|
Safe bioflavonoid.
|
|
|
Ingredients:
Vitamin C, Niacin, Luteolin (Digitoflavone), Bromelain, Quercetin,
Microcrystalline cellulose,
stearic acid, silicon dioxide, croscarmellose sodium
and magnesium stearate.
|
|
|
Directions: 1 tablet, 3 times daily.
|
|
|
May be taken with food.
|
|
|
90 tablets per bottle.
|
|
|
Do not take if allergic to pineapple or
peanuts.
|
|
 |
Shipping Information |
|
|
We ship UPS.
|
|
|
UPS will NOT ship to a P.O. Box.
|
|
|
Shipping charges are added at checkout.
|
|
|
Orders received by 12 PM
Pacific time
Monday through Friday are usually shipped the same
day. |
|
|
Express shipping is available at checkout for extra
charge. Weekends NOT included. |
|
|
Purchase receipt sent via email. When ordering, please make sure your email address
is correct. |
What is
Diabetes?
Diabetes mellitus is a group of diseases characterized by
high blood sugar levels that result from the body's inability to
make or use insulin, a hormone produced by the pancreas that
plays a vital role in metabolism. Symptoms include increased
thirst and urination, hunger, weight loss, fatigue, and blurred
vision. Diabetes can lead to debilitating and life-threatening
complications including blindness, memory problems, kidney
disease, heart disease, nerve damage, and amputations.
Type 1 Diabetes
Type 1 diabetes was previously
called insulin-dependent diabetes mellitus (IDDM) or
juvenile-onset diabetes. Type 1 diabetes develops when the
body's immune system destroys pancreatic beta cells, the only
cells in the body that make the hormone insulin that regulates
blood glucose. To survive, people with type 1 diabetes must have
insulin delivered by injection or a pump. This form of diabetes
usually strikes children and young adults, although disease
onset can occur at any age. Type 1 diabetes accounts for 5
percent to 10 percent of all diagnosed cases of diabetes. Risk
factors for type 1 diabetes may be autoimmune, genetic, or
environmental.
Type 2 Diabetes
Type 2
diabetes was previously called non-insulin-dependent diabetes
mellitus (NIDDM) or adult-onset diabetes. Type 2 diabetes
accounts for about 90 percent to 95 percent of all diagnosed
cases of diabetes. It usually begins as insulin resistance, a
disorder in which the cells do not use insulin properly. As the
need for insulin rises, the pancreas gradually loses its ability
to produce it. Type 2 diabetes is associated with older age,
obesity, a family history of diabetes, a history of gestational
diabetes, impaired glucose metabolism, physical inactivity, and
race/ethnicity. African Americans, Hispanic/Latino Americans,
American Indians, and some Asian Americans and Native Hawaiians
or other Pacific Islanders are at particularly high risk for
type 2 diabetes and its complications.
Gestational diabetes
Gestational diabetes is a
form of glucose intolerance diagnosed in some women during
pregnancy. Gestational diabetes occurs more frequently among
African Americans, Hispanic/Latino Americans, and American
Indians. It is also more common among obese women and women with
a family history of diabetes. During pregnancy, gestational
diabetes requires treatment to normalize maternal blood glucose levels to
avoid complications in the infant. After pregnancy, 5 to 10
percent of women with gestational diabetes are found to have
type 2 diabetes. Women who have had gestational diabetes have a
20 to 50 percent chance of developing diabetes in the next 5 to
10 years.
Pre-diabetes
Pre-diabetes is a
condition that occurs when a person's blood glucose levels are
higher than normal but not high enough for a diagnosis of type 2
diabetes. It is estimated that at least 20.1 million Americans
have pre-diabetes, in addition to the 20 million with diabetes.
What is
Glycemic Control?
Glycemic control
is a medical term referring to the typical levels of blood sugar
(glucose)
in a person with
diabetes mellitus.
Much evidence suggests that many of the long-term complications
of diabetes, especially the microvascular complications, result
from many years of
hyperglycemia
(elevated levels of glucose in the blood). Good glycemic
control, in the sense of a "target" for treatment, has become an
important goal of diabetes care, although recent research
suggests that the complications of diabetes may be caused by
genetic factors or, in type 1 diabetics, by the continuing
effects of the autoimmune disease which first caused the
pancreas to lose its insulin-producing ability.
Because blood sugar
levels fluctuate throughout the day and glucose records are
imperfect indicators of these changes, the percentage of
hemoglobin
which is
glycosylated
is used as a proxy measure of long-term glycemic control in
research trials and clinical care of people with diabetes. This
test, the
hemoglobin A1c
or
glycosylated hemoglobin
reflects average glucoses over the preceding 2–3 months. In
nondiabetic persons with normal glucose metabolism the
glycosylated hemoglobin is usually 4-6% by the most common
methods (normal ranges may vary by method).
"Perfect glycemic control" would mean that
glucose levels were always normal (70–130 mg/dl, or 3.9-7.2 mmol/L)
and indistinguishable from a person without diabetes. In
reality, because of the imperfections of treatment measures,
even "good glycemic control" describes blood glucose levels that
average somewhat higher than normal much of the time. In
addition, one survey of type 2 diabetics found that they rated
the harm to their quality of life from intensive interventions
to control their blood sugar to be just as severe as the harm
resulting from intermediate levels of diabetic complications.
Poor glycemic control refers to persistently
elevated blood glucose and glycosylated hemoglobin levels, which
may range from 200–500 mg/dl (11-28 mmol/L) and 9-15% or higher
over months and years before severe complications occur.
Complications of Diabetes
Heart disease and stroke
Heart
disease is the leading cause of diabetes-related deaths. Adults
with diabetes have heart disease death rates about 2 to 4 times
higher than adults without diabetes. The risk for stroke is 2 to
4 times higher among people with diabetes. About 65% of deaths
among people with diabetes are due to heart disease and stroke.
High blood pressure
About 73% of adults with
diabetes have blood pressure greater than or equal to 130/80
millimeters of mercury (mm Hg) or use prescription medications
for hypertension.
Blindness
Diabetes is the
leading cause of new cases of blindness among adults 20-74 years
old. Diabetic retinopathy causes from 12,000 to 24,000 new cases
of blindness each year.
Kidney disease
Diabetes is the leading cause of treated end-stage renal
disease, accounting for 44% of new cases. In 2002, 44,400
people with diabetes began treatment for end-stage renal
disease. In
2002 in
the United States
and Puerto Rico,153,730 people with end-stage kidney disease
due to diabetes were living on chronic dialysis or with a kidney
transplant.
Nervous system disease
About 60%
to 70% of people with diabetes have mild to severe forms of
nervous system damage. The results of such damage include
impaired sensation or pain in the feet or hands, slowed
digestion of food in the stomach, carpal tunnel syndrome, and
other nerve problems. Almost 30 percent of people with diabetes
aged 40 years or older have impaired sensation in the feet
(i.e., at least one area that lacks feeling). Severe forms of
diabetic nerve disease are a major contributing cause of
lower-extremity amputations.
Amputations
More
than 60 percent of nontraumatic lower-limb amputations occur
among people with diabetes. In 2002, about 82,000 nontraumatic
lower-limb amputations were performed in people with diabetes
Dental disease
Periodontal or gum diseases are
more common among people with diabetes than among people without
diabetes. Among young adults, those with diabetes are often at
twice the risk of those without diabetes. Almost one-third of
people with diabetes have severe periodontal diseases with loss
of attachment of the gums to the teeth measuring 5 millimeters or more.
Complications
of pregnancy
Poorly controlled diabetes before
conception and during the first trimester of pregnancy can cause
major birth defects in 5 to 10 percent of pregnancies and
spontaneous abortions in 15 to 20 percent of pregnancies. Poorly
controlled diabetes during the second and third trimesters of
pregnancy can result in excessively large babies, posing a risk
to both mother and child.
Other complications
Uncontrolled diabetes often leads to biochemical imbalances that
can cause acute life-threatening events, such as diabetic
ketoacidosis and hyperosmolar (nonketotic) coma. People with
diabetes are more susceptible to many other illnesses and, once
they acquire these illnesses, often have worse prognoses than
people without diabetes. For example, they are more likely to
die with pneumonia or influenza than people who do not have
diabetes.
|
General information and national estimates on diabetes
in the
U.S.
2005:
|
Prevalence of total diabetes in the United States, all ages, 2002
Total: 20.8 million people - 7% of the population - have
diabetes.
Diagnosed: 14.6 million people
Undiagnosed: 6.2 million people
Prevalence of total
diabetes among people under 20 years of age, U.S. 2005:
About 176,500 people aged 20 years or younger have diabetes.
This group represents 0.22 percent of all people in this age
group.
About one in every 400 to 600 children and
adolescents has type 1 diabetes.
Although type 2 diabetes
can occur among youth, the nationally representative data that
would be needed to monitor diabetes trends in youth by type are
not available. Clinically based reports and regional studies
suggest that type 2 diabetes, although still rare, is being
diagnosed more frequently in children and adolescents,
particularly in American Indians, African Americans, and
Hispanic/Latino Americans.
Prevalence of total
diabetes among people aged 20 years or older, U.S. 2005:
Age 20 years or older: 20.6 million. 9.6% of all people in
this age group have diabetes.
Age 60 years or older: 10.3
million. 20.9% of all people in this age group have diabetes.
Men: 10.9 million. 10.5% of all men aged 20 years or older
have diabetes.
Women: 9.7 million. 8.8% of all women
aged 20 years or older have diabetes.
Prevalence of
total diabetes by race/ethnicity among people aged 20 years or
older, U.S.
2005:
Whites : 13.1 million. 8.7% of all whites
aged 20 years or older have diabetes.
Blacks : 3.2
million. 13.3% of all blacks aged 20 years or older have
diabetes. On average, blacks are 1.8 times more likely to have
diabetes than whites of similar age.
Hispanic/Latino
Americans : 2.5 million. 9.5% of all Hispanic/Latino Americans
aged 20 years or older have diabetes. On average,
Hispanic/Latino Americans are 1.7 times more likely to have
diabetes than non-Hispanic whites of similar age. Mexican
Americans, the largest Hispanic/Latino subgroup, are more than
twice as likely to have diabetes than whites of similar age.
Similarly, residents of Puerto Rico are 1.8 times more likely to
have diagnosed diabetes than U.S. whites.
Sufficient data are not available to derive more specific
current estimates for other Hispanic/Latino groups.
American Indians and Alaska Natives who receive care from the
Indian Health Service (IHS): 118,000. 15.1% of American Indians
and Alaska Natives aged 20 years or older receiving care from
IHS have diabetes. At the regional level, diabetes is least
common among Alaska Natives (6.8%) and most common among
American Indians in the southeastern United States (27.6%). On average,
American Indians and Alaska Natives are 2.2 times more likely to
have diabetes than whites of similar age.
Asian Americans
and Native Hawaiian or other Pacific Islanders: Native Hawaiians
and Japanese and Filipino residents of
Hawaii
were approximately two times more likely to have diagnosed
diabetes than white residents of
Hawaii
of similar age. Prevalence data for diabetes among other Pacific
Islanders or Asian Americans are limited, but some groups within
these populations are at increased risk for diabetes.
Incidence of diabetes,
United States, 2005:
New
cases diagnosed per year : 1.5 million people aged 20 years or
older.
Deaths among people with diabetes,
United States, 2002
Diabetes was
the sixth leading cause of death listed on U.S. death
certificates in 2002. This is based on the 73,249 death
certificates in which diabetes was listed as the underlying
cause of death. Altogether, diabetes contributed to 224,029
deaths.
Diabetes is likely to be under reported as a
cause of death because many decedents with diabetes do not have
the disease entered on their death certificate. Studies have
found that only about 35% to 40% have it listed anywhere on the
certificate and only about 10% to 15% have it listed as the
underlying cause of death.
Overall, the risk for death
among people with diabetes is about 2 times that of people
without diabetes.
|
Complications of diabetes in the United States
|
Cost of diabetes in the
U.S.
2002:
Total (direct and indirect) : $132 billion
Direct medical costs : $92 billion
Indirect costs : $40
billion (disability, work loss, premature mortality)
Contents of this
website are for informational purposes only and should not take
the place of advice and guidance from your own health-care
provider. Check with your doctor about changes in your treatment
plan. Always seek the advice of your physician or qualified
health provider with any questions you may have regarding a
medical condition.
|
|
